BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification

BGI Genomics prioritizes compliance management and strictly follows laws, regulations, and international practices while conducting business globally. BGI ...

June 30, 2023 | News

Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D

This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...

June 29, 2023 | News

Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment

Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...

June 29, 2023 | News

OBiO Technology adds scale-X™ and NevoLine™ Upstream Platform to Accelerate Gene Therapy Manufacturing in Shanghai

The strategic agreement combines the capacity and capabilities of OBiO process development (PD) scientists with enabling platforms and support from...

June 28, 2023 | News

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership

As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it...

June 28, 2023 | News

CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.

The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...

June 27, 2023 | News

HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.

OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...

June 27, 2023 | News

Innovent and RemeGen Collaborate on Clinical Trial for Combined Therapy of TYVYT® and Novel ADCs in China

Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...

June 26, 2023 | News

Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693

Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...

June 26, 2023 | News

Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress

The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...

June 21, 2023 | News

AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 19, 2023 | News

SeekIn paves the way for cancer early detection in low- and middle-income countries

The overall accuracy of TOO prediction in the true positives is 66.8%, which may be supportive in the clinical diagnostic workup. OncoSeek® ...

June 19, 2023 | News

FDA Approves Phase I/II Trial for Leads Biolabs' Anti-MUC16/CD3 Bispecific Antibody in Advanced Solid Tumors.

The study is a multicenter, open-label, dose-escalation and expansion phase Ⅰ/Ⅱ clinical study. The phase Ⅰ part aims to evaluate the safety, to...

June 19, 2023 | News

EW Group Partners with China's Sinopharm, the Largest Healthcare Provider.

EW Group represented by Chairman, Prof. Dato' Sri Dr Mike Chan, and HK VJM Ltd was represented by Mr Guo Liang, while NCL Solutions Sdn Bhd repre...

June 15, 2023 | News

Stay Connected